CN Patent

CN106188016A — 盐酸达卡他韦的二水合物及其制备方法

Assigned to Fujian Cosunter Pharmaceutical Co Ltd · Expires 2016-12-07 · 9y expired

What this patent protects

本发明涉及盐酸达卡他韦的二水合物及其制备方法，所述盐酸达卡他韦二水合物，其X‑射线粉末衍射图中，在衍射角(2θ)＝9.574，11.901，13.188，18.603，20.865，22.608，23.362，24.733，25.201，26.879，27.034,29.101,30.410,33.480,35.221处有特征吸收峰，本发明还提供了该二水合物的制备方法和用途。

USPTO Abstract

本发明涉及盐酸达卡他韦的二水合物及其制备方法，所述盐酸达卡他韦二水合物，其X‑射线粉末衍射图中，在衍射角(2θ)＝9.574，11.901，13.188，18.603，20.865，22.608，23.362，24.733，25.201，26.879，27.034,29.101,30.410,33.480,35.221处有特征吸收峰，本发明还提供了该二水合物的制备方法和用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN106188016A
Jurisdiction
CN
Classification
—
Expires
2016-12-07
Drug substance claim
No
Drug product claim
No
Assignee
Fujian Cosunter Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.